An interventional study of DM199 in Pre-Eclampsia, sponsored by DiaMedica Therapeutics Inc. Withdrawn. Open to female participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2025-06-04.
Sponsored by DiaMedica Therapeutics Inc · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This entry was submitted in error by DiaMedica Therapeutics, Inc. and was not authorized by any of the trial Investigators or study sponsor (Stellenbosch University).
The clinical trial, DM199 for Pregnancy Complications, was prospectively registered with the Pan African Clinical Trials Registry (PACTR202404895013782), in accordance with ICMJE and WHO requirements. This listing serves as the primary and authoritative registration record for this investigator-initiated study.
918 studies on the registry are indexed under Pre-Eclampsia; 245 are open to participants now.
Browse Pre-Eclampsia studies →DiaMedica Therapeutics Inc is the lead sponsor of 7 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Please refer to the Pan African Clinical Trials Registry (PACTR202404895013782).
Part 1
Biological: DM199
DM199 is a synthetic form of rhKLK1
Incidence of treatment adverse events
Time frame: Until 6 weeks after the due date
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for May 2025; primary completion for May 2025, 0 months later.
How these figures are worked out, and which studies are left out of them.
This study is withdrawn, as verified in May 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: DM199
DiaMedica Therapeutics Inc